Collegium Pharmaceutical Inc. (COLL) Financial Statements (2025 and earlier)

Company Profile

Business Address 100 TECHNOLOGY CENTER DRIVE
STOUGHTON, MA 02072
State of Incorp. VA
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments162,763310,548173,688186,426174,116170,019
Cash and cash equivalent70,565238,947173,688186,426174,116170,019
Short-term investments92,19871,601    
Restricted cash and investments25,000     
Receivables228,540179,525183,119105,84483,32072,953
Inventory, net of allowances, customer advances and progress billings35,56032,33246,50117,39415,6149,643
Inventory35,56032,33246,50117,39415,6149,643
Prepaid expense 7,2705,9385,6143,6023,2801,222
Other current assets 2,74293572760141
Other undisclosed current assets20,3829,16411,0102,2501,4981,742
Total current assets:482,257537,600419,989315,543277,888255,720
Noncurrent Assets
Operating lease, right-of-use asset5,8226,0296,8617,6448,3919,047
Property, plant and equipment14,32915,98319,52119,49118,98811,854
Intangible assets, net (including goodwill), including:1,053,735555,565701,163268,723335,90429,503
Goodwill162,333133,857133,695   
Intangible assets, net (excluding goodwill)891,402421,708567,468268,723335,904 
Other undisclosed intangible assets, net (including goodwill)      29,503
Restricted cash and investments  1,0472,5472,5472,547 
Deferred income tax assets98,03326,25923,95078,042  
Other noncurrent assets8,36882510087123178
Other undisclosed noncurrent assets1,047     
Total noncurrent assets:1,181,334605,708754,142376,534365,95350,582
TOTAL ASSETS:1,663,5911,143,3081,174,131692,077643,841306,302
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities76,05846,26339,62333,40334,67239,727
Accounts payable3,9348,6923,4944,18910,0166,247
Accrued liabilities72,12437,57136,12929,21424,65633,480
Debt64,583183,333162,50048,35347,4954,489
Estimated litigation liability    2,750  
Business combination, contingent consideration, liability28,956     
Other undisclosed current liabilities339,913228,319231,603195,060157,284157,549
Total current liabilities:509,510457,915433,726279,566239,451201,765
Noncurrent Liabilities
Long-term debt and lease obligation787,905483,838538,451209,583218,35917,105
Long-term debt, excluding current maturities787,905483,838538,451201,632209,5947,667
Liabilities, other than long-term debt70,9126,1247,112   
Deferred revenue10,000     
Deferred income tax liabilities 54,191     
Operating lease, liability5,5396,1247,1127,9518,7659,438
Business combination, contingent consideration, liability1,182     
Other undisclosed noncurrent liabilities66,422  (7,951)(8,765) 
Total noncurrent liabilities:925,239489,962545,563209,583218,35917,105
Total liabilities:1,434,749947,877979,289489,149457,810218,870
Equity
Equity, attributable to parent228,842195,431194,842202,928186,03187,432
Common stock403837363534
Treasury stock, value(197,505)(137,381)(61,924)(42,861)  
Additional paid in capital590,251565,949538,073502,095519,143447,297
Accumulated other comprehensive income5514    
Accumulated deficit(163,999)(233,189)(281,344)(256,342)(333,147)(359,899)
Total equity:228,842195,431194,842202,928186,03187,432
TOTAL LIABILITIES AND EQUITY:1,663,5911,143,3081,174,131692,077643,841306,302

Income Statement (P&L) ($ in thousands)

3/31/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues631,449566,767463,933276,868310,016296,701
Cost of revenue
(Cost of Product and Service Sold)
(254,105)(240,598)(254,445)(126,251)(130,180)(193,660)
Gross profit:377,344326,169209,488150,617179,836103,041
Operating expenses(207,449)(159,208)(176,169)(132,989)(123,604)(126,789)
Operating income (loss):169,895166,96133,31917,62856,232(23,748)
Nonoperating income
(Investment Income, Nonoperating)
13,97615,6151,047122321,935
Interest and debt expense(85,303)(106,843)(63,213)(21,014)(28,882)(909)
Income (loss) from continuing operations before income taxes:98,56875,733(28,847)(3,374)27,582(22,722)
Income tax expense (benefit)(29,378)(27,578)3,84574,891(830) 
Income (loss) from continuing operations:69,19048,155(25,002)71,51726,752(22,722)
Income (loss) before gain (loss) on sale of properties:71,51726,752(22,722)
Net income (loss) available to common stockholders, basic:69,19048,155(25,002)71,51726,752(22,722)
Interest on convertible debt5,8635,889 4,675  
Net income (loss) available to common stockholders, diluted:75,05354,044(25,002)76,19226,752(22,722)

Comprehensive Income ($ in thousands)

3/31/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income (loss):69,19048,155(25,002)71,51726,752(22,722)
Other comprehensive income      
Comprehensive income (loss):69,19048,155(25,002)71,51726,752(22,722)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent4114    
Comprehensive income (loss), net of tax, attributable to parent:69,23148,169(25,002)71,51726,752(22,722)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: